Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Tonix Pharmaceuticals Holding (TNXP) FCF Margin (2023 - 2025)

Tonix Pharmaceuticals Holding has reported FCF Margin over the past 3 years, most recently at 793.25% for Q4 2025.

  • Quarterly results put FCF Margin at 793.25% for Q4 2025, down 22652.0% from a year ago — trailing twelve months through Dec 2025 was 787.46% (down 18270.0% YoY), and the annual figure for FY2025 was 787.46%, down 18270.0%.
  • FCF Margin for Q4 2025 was 793.25% at Tonix Pharmaceuticals Holding, up from 866.84% in the prior quarter.
  • Over the last five years, FCF Margin for TNXP hit a ceiling of 449.14% in Q2 2024 and a floor of 866.84% in Q3 2025.
  • Median FCF Margin over the past 3 years was 682.79% (2025), compared with a mean of 684.99%.
  • Biggest five-year swings in FCF Margin: surged 23280bps in 2024 and later crashed -31928bps in 2025.
  • Tonix Pharmaceuticals Holding's FCF Margin stood at 602.75% in 2023, then grew by 6bps to 566.73% in 2024, then tumbled by -40bps to 793.25% in 2025.
  • The last three reported values for FCF Margin were 793.25% (Q4 2025), 866.84% (Q3 2025), and 768.42% (Q2 2025) per Business Quant data.